Essential Hypertension. Essential (primary) hypertension
Conditions
Interventions
Intervention 1: Intervention group 1: In this group, 68 patients randomly undergo 24-hour ambulatory blood pressure monitoring with blood pressure holter and then combination fix dose of Valsartan 80m
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: New case of hypertension stage 1 or 2 hypertension
Exclusion criteria
Exclusion criteria: Severe hypertension Secondary hypertension Positive history of ischemic heart disease Patients on anti-hypertensive drugs beforehand Patients who are not volunteered
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average 24-hour systolic and diastolic blood pressure. Timepoint: At the beginning of the study and 60 days after starting treatment. Method of measurement: Holter monitoring of blood pressure.;Mean arterial pressure. Timepoint: At the beginning of the study and 60 days after starting treatment. Method of measurement: Holter monitoring of blood pressure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Average daytime systolic and diastolic blood pressure. Timepoint: At the beginning of the study and 60 days after starting treatment. Method of measurement: Holter monitoring of blood pressure.;Average nighttime systolic and diastolic blood pressure. Timepoint: At the beginning of the study and 60 days after starting treatment. Method of measurement: Holter monitoring of blood pressure. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKimia Falamarzi
Shiraz University of Medical Sciences
Outcome results
None listed